A number of animal protection organizations are calling on people to make a call for chimps being used in experimentation during National Call in Week for Chimps, and there’s still time to make a call.
First introduced in 2008, the Great Ape Protection Act has been reintroduced with bipartisan support in both the House of Representatives and the Senate as the Great Ape Protection and Cost Savings Act, now H.R. 1513 and S. 810.
The Act would phase out testing for about 1,000 chimpanzees currently in U.S. labs, along with retiring 500 federally owned chimpanzees to sanctuaries, which will save taxpayers approximately $300 million over the next ten years, while marking a milestone for animals by making this the first time a species has been exempted from testing in this country.
Additionally, it would end transport and breeding programs for all great apes intended for research, including chimpanzees, bonobos, gorillas, orangutans and gibbons, along with banning federally funded chimpanzee breeding programs.
The U.S. is now one of only two countries in the world to use chimpanzees in invasive experiments, despite what we know about their intelligence, sensitivity, complex emotional lives and social needs. According to the Animal Legal Defense Fund, more than $200 million has been spent on research using chimpanzees over the past decade.
Whether they’re captured from the wild, or bred in captivity, primates suffer from the effects of confinement without their psychological and behavioral needs being met, never mind the research part, which can include prolonged immobilization, sensory deprivation, social isolation and invasive surgery, among other horrors.
Please take a minute to make a call to your member of Congress today for asking them to co-sponsor this historic piece of legislation that will put an end to experiments on chimps and save taxpayers millions of dollars annually, and sign the petition below.
Photo credit: AfrikaForce via flickr
Disclaimer: The views expressed above are solely those of the author and may
not reflect those of
Care2, Inc., its employees or advertisers.